Organogenesis Holdings Inc. (ORGO)
Makes skin and wound healing products from human and animal tissue grafts.
$2.53-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-43.9%
The outlook
ORGO is trading near its 52-week low with mixed momentum against its moving averages. The single analyst covering the stock has a Hold rating, while the average price target sits about 19% above the current price. Overall sentiment leans neutral, reflecting the stock's weak recent positioning.
What’s behind the score
Analyst consensusHold — 3.0 avg of 1 analysts
Price trendMixed vs its moving averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +19% vs current price
Market cap
$325.5M
52-wk high
$7.08
52-wk low
$2.04
50-day avg
$2.47
200-day avg
$3.48
Trailing P/E
—